Zerbaxa - direct healthcare professional communication (DHPC)

Ceftolozane / tazobactam

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): GLOBAL RECALL: Zerbaxa (ceftolozane / tazobactam) 1 g/0.5 g powder for concentrate for solution for infusion

Key facts

• Medicine name:
  Zerbaxa
• Active substance:
  • Ceftolozane
  • tazobactam
• Therapeutic area (MeSH):
  Bacterial Infections
• Procedure number:
  EMEA/H/C/003772
• DHPC type:
  Quality defect
• Human ATC codes:
  J01
• Dissemination date:
  23/12/2020